| | Class 1 Device Recall TriFlo''" Subglottic Suction System |  |
| Date Initiated by Firm | June 20, 2018 |
| Date Posted | August 21, 2018 |
| Recall Status1 |
Terminated 3 on July 28, 2020 |
| Recall Number | Z-2826-2018 |
| Recall Event ID |
80508 |
| Product Classification |
Catheters, suction, tracheobronchial - Product Code BSY
|
| Product | The Tri-Flo Subglottic Suction System |
| Code Information |
Part number: CM28010; Lot/Serial Numbers: 0001158835 , 0001158836, 0001158837, 0001185564, 0001194114 , 0004008255, 0004008256. |
| FEI Number |
2050001
|
Recalling Firm/ Manufacturer |
Vyaire Medical 26125 N Riverwoods Blvd Mettawa IL 60045-3420
|
Manufacturer Reason for Recall | Vyaire Medical has discovered potential patient safety risk with associated with the Tri-Flow Subglottic Suction System. The distal soft tip of the catheter has been identified as having the potential to break off during patient use and result in aspiration of a solid foreign body. |
FDA Determined Cause 2 | Process control |
| Action | The firm notified its customers on/about 06/20/2018 via a letter entitled " URGENT: Tri-Flo" Subglottic Suction System RECALL NOTIFICATION". This letter described the affected part, and lot numbers as well as the distribution dates for affected part numbers. The letter described the following actions to be taken by the customer which include:
1) Inspect current inventory on-hand. A 100% physical inventory should immediately be performed to identify and remove the Tri-Flo TM Subglottic Suction Systems (CM28010) from distribution due to the identified potential patient safety risk.
2) If a facility has further distributed affected product, Vyaire states a entity must further notify customers of this URGENT RECALL NOTIFICATION .
3) Return all in-stock inventory affected by this recall by calling Vyaire's Customer Service Support team at 833-3BREATH (833-327-3284) (Option #1) Monday-Friday 7:00 am CST- 5:30 pm CST to obtain a pre-paid shipping Return Goods Authorization (RGA). Requests for credit can be made by providing the original P.O. number for in-stock inventory.
4) Complete the Customer Response Form (Appendix 1) and return to GMB-GLB VSFieldActions@Vyaire.com.
The letter also included instructions if an end-user customer/ facility that did not purchase the product directly through Vyaire Medical, to work with the distributor to return or receive credit for in-stock inventory affected by this recall.
Any additional questions concerning this voluntary Recall, the firm recommended contacting Lindy Schenning at 1.872.757.0109 or via e-mail at Lindy.Schenning@Vyaire .com. |
| Quantity in Commerce | 2150 Units Total |
| Distribution | Domestic Distribution: AZ, CA, CT, FL, GA, IA, IL, IN, MA, MD, MN, NJ, OH, OK, SD, TX, WA, WI. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|